Cardiol Therapeutics Inc. (TSX:CRDL)
1.780
-0.070 (-3.78%)
Oct 9, 2026, 4:00 PM EST
Cardiol Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
207.94M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 78.76K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cresco Labs | 924.67M |
| Ascend Wellness Holdings | 693.48M |
| TerrAscend | 374.77M |
| Organigram Global | 309.18M |
| Auxly Cannabis Group | 165.57M |
| Medexus Pharmaceuticals | 146.70M |
| Cannara Biotech | 117.33M |
| HLS Therapeutics | 79.87M |
Cardiol Therapeutics News
- 11 days ago - Tejara Capital Ltd Expands Stake in Cardiol Therapeutics Inc (CRDL) with 1.27 Million Share Purchase - GuruFocus
- 17 days ago - Cardiol Therapeutics Slides: Corporate presentation - Filings
- 17 days ago - Cardiol Therapeutics (CRDL) Advances MAVERIC Phase III Trial, Market Implies High Growth ... - GuruFocus
- 17 days ago - Cardiol Therapeutics achieves enrollment target for Phase III MAVERIC trial - TheFly
- 17 days ago - Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy - PRNewsWire
- 24 days ago - Cardiol Therapeutics (CRDL) Raises $7M via Warrants, Extends Runway into 2028 - GuruFocus
- 24 days ago - Cardiol Therapeutics Registration statement: Registration filing - Filings
- 24 days ago - Cardiol Therapeutics receives over $7M in proceeds from warrant exercise - TheFly